Dutch company Kadans continues Oxford expansion

Kadans Science Partner will add Windrush Innovation Centre in Oxford, UK to its Pan-European portfolio. The company intends to demolish the existing building and create over 60,000 sq ft of new high specification laboratory and office space in partnership with the tenant, Oxford Biomedica.

Oxford is a global centre of excellence in life science innovation. The cluster is anchored by the University of Oxford which was recently named the number 1 University in the world (Times World University Ranking 2022). The Oxford cluster spans a whole range of life sciences enterprise including drug discovery, diagnostics, medical devices, regenerative medicine and genomics. With world leading academics, researchers and clinicians Oxford continues to be at the forefront of scientific innovation.

James Sheppard, Managing Director (UK & Ireland) said: ‘We are delighted to continue to be building our portfolio in Oxford. The development at Windrush Innovation Centre will provide much needed, high specification, laboratory space in the Oxford market. We look forward to a continued productive relationship with the tenant, Oxford Biomedica, as they build their position as a quality and innovation-led viral vector CDMO.’

With the acquisition of Windrush Innovation Centre the Kadans portfolio now comprises of over 50 buildings and numerous projects under development in the Netherlands, United Kingdom, Germany, Belgium, France and Spain. Kadans aspires to partner with universities, venture capital firms and innovative organisations to create one strong knowledge-sharing ecosystem of scientific enterprise across Europe.